Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on May 28, 2009

Arteriosclerosis, Thrombosis, and Vascular Biology. 2009
Published online before print May 28, 2009, doi: 10.1161/ATVBAHA.109.187146
A more recent version of this article appeared on August 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/8/1164    most recent
ATVBAHA.109.187146v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Zhang, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Zhang, C.
Related Collections
Right arrow Type 2 diabetes
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

Submitted on February 27, 2009
Accepted on May 15, 2009

Resveratrol Improves Endothelial Function. Role of TNF{alpha} and Vascular Oxidative Stress

Hanrui Zhang ; Jing Zhang ; Zoltan Ungvari ; and Cuihua Zhang *

From the Department of Internal Medicine, Medical Pharmacology & Physiology and Nutritional Sciences (H.Z., J.Z., C.Z.), Dalton Cardiovascular Research Center, University of Missouri, Columbia; the Department of Physiology (Z.U.), New York Medical College, Valhalla; and the Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine (Z.U.), University of Oklahoma Health Science Center, Oklahoma City.

* To whom correspondence should be addressed. E-mail: ZhangCu{at}missouri.edu.

Objective—Oxidative stress plays an important role in type 2 diabetes–related endothelial dysfunction. We hypothesized that resveratrol protects against oxidative stress–induced endothelial dysfunction in aortas of diabetic mice by inhibiting tumor necrosis factor {alpha} (TNF{alpha})-induced activation of NAD(P)H oxidase and preserving phosphorylation of endothelial nitric oxide synthase (eNOS).

Methods and Results—We examined endothelial-dependent vasorelaxation to acetylcholine (ACh) in diabetic mice (Leprdb) and normal controls (m Leprdb). Relaxation to ACh was blunted in Leprdb compared with m Leprdb, whereas endothelial-independent vasorelaxation to sodium nitroprusside (SNP) was comparable. Resveratrol improved ACh-induced vasorelaxation in Leprdb without affecting dilator response to SNP. Impaired relaxation to ACh in Leprdb was partially reversed by incubating the vessels with NAD(P)H oxidase inhibitor apocynin and a membrane-permeable superoxide dismutase mimetic TEMPOL. Dihydroethidium (DHE) staining showed an elevated superoxide (O2·-) production in Leprdb, whereas both resveratrol and apocynin significantly reduced O2·- signal. Resveratrol increased nitrite/nitrate levels and eNOS (Ser1177) phosphorylation, and attenuated H2O2 production and nitrotyrosine (N-Tyr) content in Leprdb aortas. Furthermore, resveratrol attenuated the mRNA and protein expression of TNF{alpha}. Genetic deletion of TNF{alpha} in diabetic mice (dbTNF-/dbTNF-) was associated with a reduced NAD(P)H oxidase activity and vascular O2·- production and an increased eNOS (Ser1177) phosphorylation, suggesting that TNF{alpha} plays a pivotal role in aortic dysfunction in diabetes by inducing oxidative stress and reducing NO bioavailability.

Conclusions—Resveratrol restored endothelial function in type 2 diabetes by inhibiting TNF{alpha}-induced activation of NAD(P)H oxidase and preserving eNOS phosphorylation, suggesting the potential for new treatment approaches to promote vascular health in metabolic diseases.


Key words: antioxidants • nitric oxide • nitric oxide synthase • superoxide • vasodilation